ChatGJP: Exposomics, PFAS, and Clinical Trial Implications
In this episode of ChatGJP, Panome Bio President and Co-Founder Tom Cohen explores the growing field of exposomics and its role in understanding how environmental exposures influence human health and disease. Tom also discusses PFAS (per- and polyfluoroalkyl substances), a class of persistent “forever chemicals” found in virtually all populations worldwide. Watch the conversation to learn how exposomics is helping researchers uncover previously overlooked environmental drivers of health outcomes, improve patient stratification, and better understand the factors that may influence therapeutic efficacy and safety in clinical studies.
Have a Question?
Your privacy is important to us.
We’ll never share your information.